PURPOSE: This study aimed to prospectively investigate F-FDG PET/CT role for the assessment of sarcoidosis activity and extension in comparison with thoracic high-resolution CT (HRCT) and to evaluate the potential clinical impact of PET/CT findings. Secondary aim was to investigate the changes in cardiac FDG uptake related to the specific preparation before PET/CT. METHODS: We prospectively enrolled biopsy proven sarcoidosis patients consecutively referred for F-FDG PET/CT since January 2010. PET/CT was performed after a fat meal followed by 12-hour fasting and compared with thoracic HRCT results obtained in supine position and clinical follow-up. The impact on the clinical management was recorded.Patterns of cardiac FDG uptake of the st...
Background: F-18-FDG PET/CT (PET) is useful in assessing inflammatory activity in sarcoidosis. Howev...
Background Sarcoidosis is characterized by a wide range of disease manifestations. In the management...
Introduction: Cardiac involvement is linked to high mortality in sarcoidosis patients. However, the ...
PURPOSE: This study aimed to prospectively investigate F-FDG PET/CT role for the assessment of sarco...
Purpose: This study assessed the role of whole-body 18fluorodeoxyglucose positron-emission tomograph...
Abstract Background 18F-FDG PET has been used in sarcoidosis for diagnosis and determination of the ...
Background: Sarcoidosis is a multisystem granulomatous disorder of unknown origin characterized by n...
Sarcoidosis is a multisystem disease pathologically characterized by non-caseating granuloma. Cardia...
ObjectivesThis study sought to relate imaging findings on positron emission tomography (PET) to adve...
Background: Immunosuppression is used to treat cardiac sarcoidosis, despite limited data. FDG PET/CT...
Background: FDG PET/CT with myocardial perfusion imaging is a useful method for evaluating cardiac s...
PURPOSE: Fluor-18 fluorodeoxyglucose (18F-FDG) PET is able to demonstrate sarcoidosis activity. Ongo...
Background: Assessing inflammatory activity is useful in the management of persistent symptomatic sa...
Purpose of reviewIt is important to gain knowledge and understanding about the appropriate use of PE...
Background: F-18-FDG PET/CT (PET) is useful in assessing inflammatory activity in sarcoidosis. Howev...
Background Sarcoidosis is characterized by a wide range of disease manifestations. In the management...
Introduction: Cardiac involvement is linked to high mortality in sarcoidosis patients. However, the ...
PURPOSE: This study aimed to prospectively investigate F-FDG PET/CT role for the assessment of sarco...
Purpose: This study assessed the role of whole-body 18fluorodeoxyglucose positron-emission tomograph...
Abstract Background 18F-FDG PET has been used in sarcoidosis for diagnosis and determination of the ...
Background: Sarcoidosis is a multisystem granulomatous disorder of unknown origin characterized by n...
Sarcoidosis is a multisystem disease pathologically characterized by non-caseating granuloma. Cardia...
ObjectivesThis study sought to relate imaging findings on positron emission tomography (PET) to adve...
Background: Immunosuppression is used to treat cardiac sarcoidosis, despite limited data. FDG PET/CT...
Background: FDG PET/CT with myocardial perfusion imaging is a useful method for evaluating cardiac s...
PURPOSE: Fluor-18 fluorodeoxyglucose (18F-FDG) PET is able to demonstrate sarcoidosis activity. Ongo...
Background: Assessing inflammatory activity is useful in the management of persistent symptomatic sa...
Purpose of reviewIt is important to gain knowledge and understanding about the appropriate use of PE...
Background: F-18-FDG PET/CT (PET) is useful in assessing inflammatory activity in sarcoidosis. Howev...
Background Sarcoidosis is characterized by a wide range of disease manifestations. In the management...
Introduction: Cardiac involvement is linked to high mortality in sarcoidosis patients. However, the ...